{"pub": "investing.com", "url": "https://ca.investing.com/news/stock-market-news/briefsequana-medical-first-patient-enrolled-in-north-american-alfapump-pivotal-study-poseidon-1974971", "downloaded_at": "2019-09-25 07:01:27.880104+00:00", "title": "BRIEF-Sequana Medical: First Patient Enrolled In North American Alfapump Pivotal Study (Poseidon)", "language": "en", "text": "BRIEF-Sequana Medical: First Patient Enrolled In North American Alfapump Pivotal Study (Poseidon)\n\nStock Markets 1 hour ago (Sep 25, 2019 01:20)\n\n\u00a9 Reuters. BRIEF-Sequana Medical: First Patient Enrolled In North American Alfapump Pivotal Study (Poseidon) Sept 25 (Reuters) - SEQUANA MEDICAL NV : * SEQUANA MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN NORTH AMERICAN ALFAPUMP\u00ae PIVOTAL STUDY (POSEIDON) * RESULTS ANTICIPATED BY MID-2021 * STUDY AIMS TO SUPPORT APPROVAL OF ALFAPUMP IN U.S. AND CANADA * U.S. LAUNCH OF ALFAPUMP PLANNED FOR H1 2022\n\nBRIEF-Sequana Medical: First Patient Enrolled In North American Alfapump Pivotal Study (Poseidon)", "description": "BRIEF-Sequana Medical: First Patient Enrolled In North American Alfapump Pivotal Study (Poseidon)", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXMPEB230DM_L.jpg", "published_at": "2019-09-25"}